LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
Halozyme Therapeutics
HALO
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
YETI Holdings
YETI
Dorian LPG
LPG
US Stock MarketDetailed Quotes
REGN Regeneron Pharmaceuticals
- 712.400
- -4.280-0.60%
Close Dec 27 16:00 ET
- 712.400
- 0.0000.00%
Post 20:01 ET
78.29BMarket Cap17.62P/E (TTM)
718.990High709.090Low795.58KVolume710.520Open716.680Pre Close567.10MTurnover0.76%Turnover Ratio20.49P/E (Static)109.89MShares1211.20052wk High2.67P/B75.09BFloat Cap693.00052wk Low--Dividend TTM105.40MShs Float1211.200Historical High--Div YieldTTM1.38%Amplitude4.610Historical Low712.822Avg Price1Lot Size
Regeneron Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 15.88%1.29B | -65.38%354M | 10.60%1.51B | -8.39%4.59B | -36.64%1.09B | 77.18%1.11B | 81.15%1.02B | -34.93%1.37B | -29.18%5.01B | -27.51%1.72B |
| Net income from continuing operations | 33.02%1.34B | 47.90%1.43B | -11.71%722M | -8.87%3.95B | -3.13%1.16B | -23.40%1.01B | 13.65%968.4M | -15.99%817.8M | -46.28%4.34B | -46.29%1.2B |
| Operating gains losses | -206.06%-134.7M | -1,370.55%-392.6M | 17.71%196.1M | 623.91%266.4M | 27.92%-58.1M | 150.10%127M | -81.43%30.9M | -18.53%166.6M | 109.51%36.8M | -158.58%-80.6M |
| Depreciation and amortization | 15.46%121.7M | 17.07%120.7M | 14.67%114.1M | 23.32%421M | 12.89%113M | 13.82%105.4M | 38.58%103.1M | 33.92%99.5M | 19.29%341.4M | 34.36%100.1M |
| Deferred tax | -34.13%-168.6M | 43.57%-118.1M | 12.06%-190.4M | -12.25%-837.8M | -2.36%-286.3M | -46.67%-125.7M | -34.17%-209.3M | 3.78%-216.5M | -407.41%-746.4M | -35.84%-279.7M |
| Other non cash items | -145.76%-29M | -134.88%-3M | -99.51%100K | -100.02%-100K | -110.36%-17.5M | -119.44%-11.8M | -96.55%8.6M | -75.56%20.6M | -1.00%563M | -44.46%169M |
| Change In working capital | 66.77%-63.9M | -1,017.47%-908.5M | 82.86%440.5M | 61.32%-94.1M | -116.07%-61.4M | 71.18%-192.3M | 89.59%-81.3M | -70.74%240.9M | 87.30%-243.3M | 207.48%382M |
| -Change in receivables | 16.09%-388.9M | -18,200.00%-494.1M | 112.66%446.8M | -147.87%-338.8M | -137.66%-82.7M | -19.80%-463.5M | 99.16%-2.7M | -82.46%210.1M | 136.72%707.8M | 137.57%219.6M |
| -Change in inventory | -112.95%-164.4M | -81.08%-181.8M | -232.91%-155.8M | 60.99%-271.7M | 67.22%-47.3M | 65.46%-77.2M | 58.18%-100.4M | 47.18%-46.8M | -40.91%-696.5M | 11.85%-144.3M |
| -Change in prepaid assets | 191.47%252M | -15,379.41%-526.3M | -1,316.36%-77.9M | 19.18%-120.1M | 778.61%164.3M | -327.31%-275.5M | 98.60%-3.4M | 87.72%-5.5M | 38.26%-148.6M | -75.43%18.7M |
| -Change in payables and accrued expense | -66.40%194.4M | 415.37%204.6M | -7.14%110.5M | 532.51%598.6M | -139.90%-138.7M | 460.95%578.6M | 152.72%39.7M | 147.52%119M | -115.98%-138.4M | -4.95%347.6M |
| -Change in other working capital | -5.08%43M | 714.48%89.1M | 425.63%116.9M | 16.98%37.9M | 172.15%43M | 355.93%45.3M | -114.47%-14.5M | -477.89%-35.9M | 126.96%32.4M | -21.63%-59.6M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 15.88%1.29B | -65.38%354M | 10.60%1.51B | -8.39%4.59B | -36.64%1.09B | 77.18%1.11B | 81.15%1.02B | -34.93%1.37B | -29.18%5.01B | -27.51%1.72B |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -15.74%-574.4M | 76.66%-557.2M | -615.78%-1.69B | 15.84%-3.19B | 96.44%-66.2M | -358.09%-496.3M | -476.69%-2.39B | 86.18%-235.7M | 29.72%-3.78B | 7.70%-1.86B |
| Capital expenditure reported | -37.44%-241.9M | -59.73%-180.5M | 24.86%-133.9M | -21.78%-718.6M | -65.18%-251.4M | -23.51%-176M | 26.43%-113M | -25.67%-178.2M | -6.92%-590.1M | 1.74%-152.2M |
| Net PPE purchase and sale | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net intangibles purchase and sale | --0 | -45.45%-30.4M | 72.35%-27.9M | 79.76%-207.8M | 37.90%-62.1M | 97.42%-23.9M | ---20.9M | ---100.9M | ---1.03B | ---100M |
| Net business purchase and sale | --0 | ---- | ---- | 76.16%-54.9M | ---3.8M | ---51.1M | ---- | ---- | ---230.3M | --0 |
| Net investment purchase and sale | -35.55%-332.5M | 83.96%-361.4M | -3,614.52%-1.53B | -13.75%-2.2B | 115.64%251.1M | -119.44%-245.3M | -7,410.00%-2.25B | 102.78%43.4M | 59.91%-1.94B | 13.58%-1.61B |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -15.74%-574.4M | 76.66%-557.2M | -615.78%-1.69B | 15.84%-3.19B | 96.44%-66.2M | -358.09%-496.3M | -476.69%-2.39B | 86.18%-235.7M | 29.72%-3.78B | 7.70%-1.86B |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -55.66%-634M | 22.16%-478.1M | 114.60%47.1M | -77.41%-1.79B | -80.17%-446.1M | 43.82%-407.3M | -507.52%-614.2M | -598.45%-322.5M | -0.32%-1.01B | 72.69%-247.6M |
| Net common stock issuance | -47.46%-600.6M | 22.16%-478.1M | 114.60%47.1M | -77.41%-1.79B | -80.17%-446.1M | 43.82%-407.3M | -507.52%-614.2M | -598.45%-322.5M | -0.32%-1.01B | 72.69%-247.6M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -55.66%-634M | 22.16%-478.1M | 114.60%47.1M | -77.41%-1.79B | -80.17%-446.1M | 43.82%-407.3M | -507.52%-614.2M | -598.45%-322.5M | -0.32%-1.01B | 72.69%-247.6M |
| Net cash flow | ||||||||||
| Beginning cash position | -1.10%1.93B | -33.57%2.61B | -12.23%2.74B | 7.64%3.12B | -38.36%2.16B | -42.80%1.95B | 16.96%3.93B | 7.64%3.12B | 31.30%2.9B | 1.74%3.5B |
| Current changes in cash | -60.70%82.8M | 65.57%-681.3M | -115.75%-127.5M | -272.25%-381.2M | 249.82%577.4M | 119.02%210.7M | -4,105.47%-1.98B | 75.54%809.4M | -67.96%221.3M | 29.52%-385.4M |
| Effect of exchange rate changes | 500.00%800K | 25.00%-300K | ---500K | ---400K | --200K | ---200K | ---400K | --0 | --0 | --0 |
| End cash Position | -6.87%2.01B | -1.10%1.93B | -33.57%2.61B | -12.23%2.74B | -12.23%2.74B | -38.36%2.16B | -42.80%1.95B | 16.96%3.93B | 7.64%3.12B | 7.64%3.12B |
| Free cash flow | 14.75%1.05B | -83.89%143.1M | 24.09%1.35B | 7.93%3.67B | -47.11%776.2M | 307.63%914.4M | 116.29%888.5M | -44.46%1.09B | -47.96%3.4B | -33.82%1.47B |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
